LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
about
Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons DiseaseThe role of the LRRK2 gene in ParkinsonismA visual review of the interactome of LRRK2: Using deep-curated molecular interaction data to represent biology.Parkinson's disease-implicated kinases in the brain; insights into disease pathogenesis.The LRRK2 inhibitor GSK2578215A induces protective autophagy in SH-SY5Y cells: involvement of Drp-1-mediated mitochondrial fission and mitochondrial-derived ROS signaling.The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons.Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases.Glycation potentiates neurodegeneration in models of Huntington's disease.Targeting leucine-rich repeat kinase 2 in Parkinson's disease.Protein phosphorylation in neurodegeneration: friend or foe?LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesisα-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities.Molecular changes in the postmortem parkinsonian brain.LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.LRRK2 and the Immune System.From the baker to the bedside: yeast models of Parkinson's disease.LRRK2 Promotes Tau Accumulation, Aggregation and Release.LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson's Disease Mouse Model.MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons.Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population.
P2860
Q26776209-59EEC622-0619-487E-B6C1-C2B326A7C233Q27023749-E676666C-FC59-4B3C-80FB-3DD42A054D27Q30887351-5E18A710-F70E-429C-94BF-88838B2FD3AFQ33797449-2F6FD962-68DD-4A74-B46C-AA3D8E24DD77Q35679501-18C3B865-C687-45D1-9749-DD68D553FB13Q36296532-46559BF5-75CD-4BDE-9D79-DBEA6754E5D9Q37096048-27DBEA0D-EDC1-4C41-A43C-BDD7EEB71AFAQ37119983-6520D88B-0B05-4CB2-B610-3389AAC4DCD4Q37421997-2469E2A9-AEB7-4F3D-9ED0-3037BF4C8721Q38160939-4876DD6D-8C6D-4075-BC12-33C8146F09C3Q38214594-B922866E-D6D4-4F9E-B414-007802884E41Q38218398-C0EDC970-4DA6-48A0-A3CB-2B30BE74CBFBQ38781011-8059EBE2-6975-4694-AED1-2634A48E3A49Q38887346-BF17524F-4EEB-4383-878B-CD0466D31B41Q39136594-F41A6513-D95E-40F2-911C-03BD177BF69AQ39206438-BEAF19E0-C049-42A8-BF07-9D1132B164ADQ39208122-8F0C6E28-929E-4876-A39B-69167C1112D8Q40899192-BE0A855D-B3D3-41F3-A7DC-FF513D2459F6Q41539639-F8D7B2C1-1BF1-478E-9606-BECE11B4F599Q47102033-FAAE3EB3-7667-4F0C-8079-8635EB9AE365Q51063701-A3BC17FD-0A65-4607-B7E4-5F47DDEF04C5Q51082143-662A5FE9-88A5-4FC0-AC88-8EEF0449E23AQ54977439-62820BF1-4EDA-410B-940D-472BEFFF0A17Q54988601-FC2BA69F-44F5-4A29-A659-F563294E16F7
P2860
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@ast
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@en
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@en-gb
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@nl
type
label
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@ast
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@en
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@en-gb
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@nl
prefLabel
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@ast
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@en
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@en-gb
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@nl
P2093
P2860
P50
P921
P1476
LRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell models
@en
P2093
Amanda Gysbers
Danni Cheng
Tiago Fleming Outeiro
Wei Ping Gai
P2860
P2888
P304
P356
10.1007/S00109-012-0984-Y
P407
P577
2013-04-01T00:00:00Z
P5875
P6179
1026045143